Correspondence to: Use of levodopa-carbidopa intestinal gel to treat patients with multiple system atrophy

Affiliations

¹ Neurology Department, Unidade Local de Saúde de Braga, Braga, Portugal. Electronic address: sofia.costa.lopes@ulsb.min-saude.pt.
² Neurology Department, Unidade Local de Saúde de Loures-Odivelas, Loures, Portugal.
³ Movement Disorder Unit, Neurology Department, Hospital de Sant Pau, Barcelona, Spain; Faculty of Health Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain; Medicine Department, Autonomous University of Barcelona (UAB), Barcelona, Spain; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Health Institute, Madrid, Spain.
⁴ Neurology Department, Unidade Local de Saúde de Braga, Braga, Portugal.
⁵ Movement Disorder Unit, Neurology Department, Hospital de Sant Pau, Barcelona, Spain; Medicine Department, Autonomous University of Barcelona (UAB), Barcelona, Spain; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Health Institute, Madrid, Spain.
⁶ Movement Disorder Unit, Neurology Department, Hospital de Sant Pau, Barcelona, Spain; Faculty of Health Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Health Institute, Madrid, Spain.
⁷ CNS - Campus Neurológico, Braga, Portugal.

Sofia Lopes et al. Parkinsonism Relat Disord. 2025.

. 2025 Jul 24:138:107966.

doi: 10.1016/j.parkreldis.2025.107966. Online ahead of print.

¹ Neurology Department, Unidade Local de Saúde de Braga, Braga, Portugal. Electronic address: sofia.costa.lopes@ulsb.min-saude.pt.
² Neurology Department, Unidade Local de Saúde de Loures-Odivelas, Loures, Portugal.
³ Movement Disorder Unit, Neurology Department, Hospital de Sant Pau, Barcelona, Spain; Faculty of Health Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain; Medicine Department, Autonomous University of Barcelona (UAB), Barcelona, Spain; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Health Institute, Madrid, Spain.
⁴ Neurology Department, Unidade Local de Saúde de Braga, Braga, Portugal.
⁵ Movement Disorder Unit, Neurology Department, Hospital de Sant Pau, Barcelona, Spain; Medicine Department, Autonomous University of Barcelona (UAB), Barcelona, Spain; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Health Institute, Madrid, Spain.
⁶ Movement Disorder Unit, Neurology Department, Hospital de Sant Pau, Barcelona, Spain; Faculty of Health Sciences, Universitat Oberta de Catalunya (UOC), Barcelona, Spain; Center for Networked Biomedical Research in Neurodegenerative Diseases (CIBERNED), Carlos III Health Institute, Madrid, Spain.
⁷ CNS - Campus Neurológico, Braga, Portugal.

No abstract available

Conflict of interest statement

Declaration of competing interest The authors declare no conflicts of interest related to the content of this manuscript.